Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Su, Tung Hung ^a,b   Liu, Chun Jen ^a,b   Tseng, Tai Chung ^b,c   Liu, Chen Hua ^a,b   Yang, Hung Chih ^a,b   Chen, Chi Ling ^b   Chen, Pei Jer ^a,b   Kao, Jia Horng ^a,b   Chen, Ding Shinn ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL; VIRUS LOAD;

EID: 84983723470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055916     Document Type: Article

References (37)

1. Liaw YF, Chu CM, (2009) Hepatitis B virus infection. Lancet 373: 582-592.
2. Chen DS, (1993) From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262: 369-370.
3. Chu CM, Liaw YF, (2009) Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 104: 1693-1699.
4. Liaw YF, (2011) Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review. Hepatology 53: 2121-2129.
5. Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, et al. (2011) Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology 141: 517-525.
6. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, et al. (2012) Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology 55: 68-76.
7. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, et al. (2012) High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load. Gastroenterology 142: 1140-1149.
8. Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, et al. (2010) Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 139: 483-490.
9. Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, et al. (2011) Hepatitis B surface antigen quantification: why and how to use it in 2011- a core group report. J Hepatol 55: 1121-1131.
10. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, et al. (2009) Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology. 49: 1141-1150.
11. Chan HL, Wong VW, Chim AM, Chan HY, Wong GL, et al. (2010) Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B. Aliment Pharmacol Ther. 32: 1323-1331.
12. Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, et al. (2009) Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 49: 1151-1157.
13. Su TH, Hsu CS, Chen CL, Liu CH, Huang YW, et al. (2010) Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antivir Ther. 15: 1133-1139.
14. Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, et al. (2010) A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology. 52: 1232-1241.
15. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, et al. (2010) Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 52: 508-513.
16. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, et al. (2010) Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52: 514-522.
17. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, et al. (2004) Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 41: 659-666.
18. Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, et al. (2012) Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. J Infect Dis 205: 54-63.
19. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, et al. (2007) Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 46: 1057-1070.
20. Bruix J, Sherman M, (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
21. Brunetto MR, (2010) A new role for an old marker, HBsAg. J Hepatol 52: 475-477.
22. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH, (2003) Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69: 313-323.
23. Reijnders JG, Rijckborst V, Sonneveld MJ, Scherbeijn SM, Boucher CA, et al. (2011) Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. J Hepatol 54: 449-454.
24. Kao JH, Chen PJ, Lai MY, Chen DS, (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 118: 554-559.
25. Kao JH, Chen PJ, Lai MY, Chen DS, (2002) Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40: 1207-1209.
26. Kao JH, Chen PJ, Lai MY, Chen DS, (2004) Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 72: 363-369.
27. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS, (2000) Hepatitis B genotypes and the response to interferon therapy. J Hepatol 33: 998-1002.
28. Liu CJ, Kao JH, Chen DS, (2005) Therapeutic implications of hepatitis B virus genotypes. Liver Int 25: 1097-1107.
29. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, et al. (2006) Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44: 915-924.
30. Moucari R, Martinot-Peignoux M, Mackiewicz V, Boyer N, Ripault MP, et al. (2009) Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a. Antivir Ther 14: 1183-1188.
31. Chen YC, Jeng WJ, Chu CM, Liaw YF, (2012) Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol 10: 297-302.
32. Chan HL, Wong GL, Tse CH, Chan HY, Wong VW, (2011) Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J Infect Dis 204: 408-414.
33. Taheri H, Hasanjani Roushan MR, Soleimani Amiri MJ, Pouralijan M, Bijani A, (2011) Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAg. Hepat Mon 11: 119-122.
34. Lok AS, Lai CL, Wu PC, (1988) Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 8: 766-770.
35. Tseng KC, Lei HY, Cheng PN, Young KC, Jen CM, et al. (2003) Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigen. Hepatogastroenterology 50: 1474-1477.
36. Kabir A, Keshvari M, Kashani AH, Alavian SM, (2008) Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin 4: 379-383.
37. Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, et al. (2012) Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Ann Hematol 91: 1007-1012.